Dexcom Inc
NASDAQ:DXCM 4:00:00 PM EDT
| Market Cap (Intraday) | 51.88B |
| Current PE | 95.80 |
| Forward PE | 76.45 |
| 2yr Forward PE | 60.07 |
| 10-Day MA | $136.94 |
| 50-Day MA | $128.83 |
| 200-Day MA | $114.92 |
Dexcom Inc Stock, NASDAQ:DXCM
6340 Sequence Drive, San Diego, California 92121
United States of America
Phone: +1.858.200.0200
Number of Employees: 9600
Description
DexCom, Inc. is a medical device company, which engages in the design, development, and commercialization of glucose monitoring systems for ambulatory use by people with diabetes. Its products include Dexcom G6, Dexcom G7, Dexcom Stelo, Dexcom Share, Dexcom Real-Time API, and Dexcom ONE. The company was founded by John F. Burd on May 13, 1999 and is headquartered in San Diego, CA.